Randal J. Thomas, M. King, K. Lui, N. Oldridge, I. Piña, J. Spertus
2007.9.20Journal of Cardiopulmonary Rehabilitation and Prevention
tlooto Summary
A significant limitation to these studies is the fact that patients identified as high risk undergo additional evaluation and treatment to lower their risk, thereby dampening the ability of such screening measures to accurately identify individuals at increased risk of adverse cardiovascular events.
Abstract
adverse events during CR sessions. 54 However, 1 study found that a combination of the AACVPR criteria with a comorbidity index helped improve the accuracy of risk stratification, particularly among female patients. 55 A significant limitation to these studies is the fact that patients identified as high risk undergo additional evaluation and treatment to lower their risk, thereby dampening the ability of such screening measures to accurately identify individuals at increased risk of adverse cardiovascular events. This performance measure does not cover the assessment of modifiable risk factors, such as blood pressure, cholesterol, and diabetes. Assessment of modifiable risk factors related to CVD progression and recurrent CVD events is covered in Performance Measure B-3.
Citation format
THOMAS, Randal J., et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. Journal of Cardiopulmonary Rehabilitation and Prevention, 2007, 27 5: 260–90.